|
1
|
Wen J, Min X, Shen M, Hua Q, Han Y, Zhao
L, Liu L, Huang G, Liu J and Zhao X: ACLY facilitates colon cancer
cell metastasis by CTNNB1. J Exp Clin Cancer Res. 38:4012019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hirata A, Hatano Y, Niwa M, Hara A and
Tomita H: Heterogeneity of colon cancer stem cells. Adv Exp Med
Biol. 1139:115–126. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rawla P, Sunkara T and Barsouk A:
Epidemiology of colorectal cancer: Incidence, mortality, survival,
and risk factors. Prz Gastroenterol. 14:89–103. 2019.PubMed/NCBI
|
|
4
|
Wong MC, Ding H, Wang J, Chan PS and Huang
J: Prevalence and risk factors of colorectal cancer in Asia. Intest
Res. 17:317–329. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thanikachalam K and Khan G: Colorectal
cancer and nutrition. Nutrients. 11:1642019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fearon ER and Vogelstein B: A genetic
model for colorectal tumorigenesis. Cell. 61:759–767. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun W: Angiogenesis in metastatic
colorectal cancer and the benefits of targeted therapy. J Hematol
Oncol. 5:632012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lan J, Li H, Luo X, Hu J and Wang G: BRG1
promotes VEGF-A expression and angiogenesis in human colorectal
cancer cells. Exp Cell Res. 360:236–242. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ceci C, Atzori MG, Lacal PM and Graziani
G: Role of VEGFs/VEGFR-1 signaling and its inhibition in modulating
tumor invasion: Experimental evidence in different metastatic
cancer models. Int J Mol Sci. 21:13882020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Deng F, Zhou R, Lin C, Yang S, Wang H, Li
W, Zheng K, Lin W, Li X, Yao X, et al: Tumor-secreted dickkopf2
accelerates aerobic glycolysis and promotes angiogenesis in
colorectal cancer. Theranostics. 9:1001–1014. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Uthoff SM, Duchrow M, Schmidt MHH, Broll
R, Bruch HP, Strik MW and Galandiuk S: VEGF isoforms and mutations
in human colorectal cancer. Int J Cancer. 101:32–36. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ning Y and Lenz HJ: Targeting IL-8 in
colorectal cancer. Expert Opin Ther Targets. 16:491–497. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Waugh DJ and Wilson C: The interleukin-8
pathway in cancer. Clin Cancer Res. 14:6735–6741. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bondurant KL, Lundgreen A, Herrick JS,
Kadlubar S, Wolff RK and Slattery ML: Interleukin genes and
associations with colon and rectal cancer risk and overall
survival. Int J Cancer. 132:905–915. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lurje G, Zhang W, Schultheis AM, Yang D,
Groshen S, Hendifar AE, Husain H, Gordon MA, Nagashima F, Chang HM
and Lenz HJ: Polymorphisms in VEGF and IL-8 predict tumor
recurrence in stage III colon cancer. Ann Oncol. 19:1734–1741.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liang Y, Chen Q, Du W, Chen C, Li F, Yang
J, Peng J, Kang D, Lin B, Chai X, et al: Epstein-barr virus-induced
gene 3 (EBI3) blocking leads to induce antitumor cytotoxic T
lymphocyte response and suppress tumor growth in colorectal cancer
by bidirectional reciprocal-regulation STAT3 signaling pathway.
Mediators Inflamm. 2016:32141052016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lyu S, Ye L, Wang O, Huang G, Yang F, Liu
Y and Dong S: IL-27 rs153109 polymorphism increases the risk of
colorectal cancer in Chinese Han population. Onco Targets Ther.
8:1493–1497. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lastraioli E, Lottini T, Bencini L,
Bernini M and Arcangeli A: hERG1 potassium channels: Novel
biomarkers in human solid cancers. Biomed Res Int. 2015:8964322015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Crociani O, Zanieri F, Pillozzi S,
Lastraioli E, Stefanini M, Fiore A, Fortunato A, D'Amico M,
Masselli M, De Lorenzo E, et al: hERG1 channels modulate integrin
signaling to trigger angiogenesis and tumor progression in
colorectal cancer. Sci Rep. 3:33082013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wei PL, Lee LT, Tseng LM and Huang KW:
Validation of assaying carcinoembryonic antigen in human serum by
using immunomagnetic reduction. Sci Rep. 8:100022018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vislovukh A, Vargas TR, Polesskaya A and
Groisman I: Role of 3′-untranslated region translational control in
cancer development, diagnostics and treatment. World J Biol Chem.
5:40–57. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang YF and Zhao AD: Common polymorphisms
in IL-27 genes may contribute to risk of various human diseases in
Asian populations: A meta-analysis. Med Sci Monit. 22:766–775.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jain L, Vargo CA, Danesi R, Sissung TM,
Price DK, Venzon D, Venitz J and Figg WD: The role of vascular
endothelial growth factor SNPs as predictive and prognostic markers
for major solid tumors. Mol Cancer Ther. 8:2496–2508. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kang HY, Choe EK, Park KJ and Lee Y:
Factors requiring adjustment in the interpretation of serum
carcinoembryonic antigen: A cross-sectional study of 18,131 healthy
nonsmokers. Gastroenterol Res Pract. 2017:98589312017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tsai PL, Su WJ, Leung WH, Lai CT and Liu
CK: Neutrophil-lymphocyte ratio and CEA level as prognostic and
predictive factors in colorectal cancer: A systematic review and
meta-analysis. J Cancer Res Ther. 12:582–589. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng
J, Li Y, Wang X and Zhao L: Inflammatory responses and
inflammation-associated diseases in organs. Oncotarget.
9:7204–7218. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mogensen TH: Pathogen recognition and
inflammatory signaling in innate immune defenses. Clin Microbiol
Rev. 22:240–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu W, He Y, Wang Y, Li X, Young J,
Ioannidis JPA, Dunlop MG and Theodoratou E: Risk factors and risk
prediction models for colorectal cancer metastasis and recurrence:
An umbrella review of systematic reviews and meta-analyses of
observational studies. BMC Med. 18:1722020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Singel KL and Segal BH: Neutrophils in the
tumor microenvironment: Trying to heal the wound that cannot heal.
Immunol Rev. 273:329–343. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yan C, Hu Y, Zhang B, Huang K, Zhao H, Ma
C, Li X, Tao D, Gong J and Qin J: The CEA-/lo colorectal cancer
cell population harbors cancer stem cells and metastatic cells.
Oncotarget. 7:80700–80715. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee YJ, Lee HR, Nam CM, Hwang UK and Jee
SH: White blood cell count and the risk of colon cancer. Yonsei Med
J. 47:646–656. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fares J, Fares MY, Khachfe HH, Salhab HA
and Fares Y: Molecular principles of metastasis: A hallmark of
cancer revisited. Signal Transduct Target Ther. 5:282020.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Saito G, Sadahiro S, Kamata H, Miyakita H,
Okada K, Tanaka A and Suzuki T: Monitoring of serum
carcinoembryonic antigen levels after curative resection of colon
cancer: Cutoff values determined according to preoperative levels
enhance the diagnostic accuracy for recurrence. Oncology.
92:276–282. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Doll D, Keller L, Maak M, Boulesteix AL,
Siewert JR, Holzmann B and Janssen KP: Differential expression of
the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and
their impact on metastatic disease and survival. Int J Colorectal
Dis. 25:573–581. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nguyen HT and Duong HQ: The molecular
characteristics of colorectal cancer: Implications for diagnosis
and therapy. Oncol Lett. 16:9–18. 2018.PubMed/NCBI
|
|
37
|
Ankathil R, Mustapha MA, Abdul Aziz AA,
Mohd Shahpudin SN, Zakaria AD, Abu Hassan MR and Musa KI:
Contribution of genetic polymorphisms of inflammation response
genes on sporadic colorectal cancer predisposition risk in
Malaysian patients-a case control study. Asian Pac J Cancer Prev.
20:1621–1632. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Huang S, Mills L, Mian B, Tellez C,
McCarty M, Yang XD, Gudas JM and Bar-Eli M: Fully humanized
neutralizing antibodies to interleukin-8 (ABX–IL8) inhibit
angiogenesis, tumor growth, and metastasis of human melanoma. Am J
Pathol. 161:125–134. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yoshimoto T, Chiba Y, Furusawa J, Xu M,
Tsunoda R, Higuchi K and Mizoguchi I: Potential clinical
application of interleukin-27 as an antitumor agent. Cancer Sci.
106:1103–1110. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Oniki S, Nagai H, Horikawa T, Furukawa J,
Belladonna ML, Yoshimoto T, Hara I and Nishigori C: Interleukin-23
and interleukin-27 exert quite different antitumor and vaccine
effects on poorly immunogenic melanoma. Cancer Res. 66:6395–6404.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kourko O, Seaver K, Odoardi N, Basta S and
Gee K: IL-27, IL-30, and IL-35: A cytokine triumvirate in cancer.
Front Oncol. 9:9692019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fabbi M, Carbotti G and Ferrini S: Dual
roles of IL-27 in cancer biology and immunotherapy. Mediators
Inflamm. 2017:39580692017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Park YJ, Ryu H, Choi G, Kim BS, Hwang ES,
Kim HS and Chung Y: IL-27 confers a protumorigenic activity of
regulatory T cells via CD39. Proc Natl Acad Sci USA. 116:3106–3111.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Diakowska D, Lewandowski A,
Markocka-Mączka K and Grabowski K: Concentration of serum
interleukin-27 increase in patients with lymph node metastatic
gastroesophageal cancer. Adv Clin Exp Med. 22:683–691.
2013.PubMed/NCBI
|
|
45
|
Lu D, Zhou X, Yao L, Liu C, Jin F and Wu
Y: Clinical implications of the interleukin 27 serum level in
breast cancer. J Investig Med. 62:627–631. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Di Carlo E, Sorrentino C, Zorzoli A, Di
Meo S, Tupone MG, Ognio E, Mincione G and Airoldi I: The antitumor
potential of Interleukin-27 in prostate cancer. Oncotarget.
5:10332–10341. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Izawa N, Shitara K, Masuishi T, Denda T,
Yamazaki K, Moriwaki T, Okuda H, Kondoh C, Nishina T, Makiyama A,
et al: Vascular endothelial growth factor (VEGF)-D and clinical
outcomes in metastatic colorectal cancer (mCRC) patients (pts)
treated with second-line FOLFIRI plus bevacizumab (Bev): A
biomarker study of the WJOG 6210G trial. J Clin Oncol. 38 (Suppl
4):S2262020. View Article : Google Scholar
|
|
48
|
Cao D, Hou M, Guan YS, Jiang M, Yang Y and
Gou HF: Expression of HIF-1alpha and VEGF in colorectal cancer:
Association with clinical outcomes and prognostic implications. BMC
Cancer. 9:4322009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Raluca BA, Cimpean AM, Cioca A, Cretu O,
Mederle O, Ciolofan A, Gaje P and Raica M: Endothelial cell
proliferation and vascular endothelial growth factor expression in
primary colorectal cancer and corresponding liver metastases. Asian
Pac J Cancer Prev. 16:4549–4553. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jubb AM, Hurwitz HI, Bai W, Holmgren EB,
Tobin P, Guerrero AS, Kabbinavar F, Holden SN, Novotny WF, Frantz
GD, et al: Impact of vascular endothelial growth factor-a
expression, thrombospondin-2 expression, and microvessel density on
the treatment effect of bevacizumab in metastatic colorectal
cancer. J Clin Oncol. 24:217–227. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Fiore A, Carraresi L, Morabito A, Polvani
S, Fortunato A, Lastraioli E, Femia AP, De Lorenzo E, Caderni G and
Arcangeli A: Characterization of hERG1 channel role in mouse
colorectal carcinogenesis. Cancer Med. 2:583–594. 2013. View Article : Google Scholar : PubMed/NCBI
|
